Copper and zinc levels in kidney failure patients
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at the balance of two minerals (copper and zinc) in people with kidney failure on dialysis, to see if their levels relate to health outcomes. It may help doctors better manage nutrition for kidney patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have end-stage renal disease (kidney failure that requires dialysis or a transplant).
- You should not have an active infection or inflammatory condition (like sepsis or an autoimmune disease).
- You should not have moderate to severe liver cirrhosis (scarring of the liver).
- You should not have had a recent hospitalization, surgery, or blood transfusion within the last 3 months.
- You cannot be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether the amount of zinc in your blood is related to how severe your diabetic kidney disease is. It might help doctors understand if zinc could be a useful marker for kidney health in diabetes.
This study looks at whether blood zinc levels are related to lupus nephritis, a kidney problem that can happen in people with lupus. If you have lupus nephritis, your blood zinc level may help doctors understand your condition better.
This trial tests whether zinc supplements can lower high homocysteine levels better than folic acid in people with chronic kidney disease who are on hemodialysis. It aims to find a simple, safe way to help protect your heart and blood vessels.
This study is looking at what happens to copper levels in the urine when people with Wilson disease briefly stop their medicine. It may help doctors understand how well your body controls copper without treatment.
This trial tests whether closely managing potassium levels during hemodialysis can help protect the heart in patients with kidney failure who are on maintenance dialysis. It aims to reduce the risk of heart problems related to potassium swings.
This study tests if taking zinc supplements can improve bone health in people with sickle cell disease. It's for those with certain types of sickle cell disease (SS or S-Beta zero thalassemia) who are not on chronic transfusions or zinc supplements.
Hear when a new Control Condition trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.